Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.47 |
| ▸ | RELA | Q04206 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.46 |
| ▸ | CA6 | P23280 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30414903 | 1.00 | KDM4E (0.48) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL30414825 | 0.96 | KDM4E (0.46) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL29762008 | 0.90 | CYP1A2 (0.54) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL11249253 | 0.90 | CYP1A2 (0.54) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| Hydrochloric Acid SCHEMBL11595018 | 0.90 | CYP1A2 (0.50) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL28456554 | 0.90 | TTR (0.49) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL11244432 | 0.89 | CYP1A2 (0.53) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL11253003 | 0.87 | BCKDK (0.58) | NPC1RAB9ATSHRTBXAS1BCKDK | |
| SCHEMBL2486863 | 0.87 | KDM4E (0.46) | KDM4ENPC1RAB9AL3MBTL1TDP1 | |
| SCHEMBL11240719 | 0.84 | BCL2L1 (0.49) | KDM4ENPC1RAB9AL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117510814-B | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117510814-A | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-117510814-B | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117510814-B | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117510814-A | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-117510814-A | Liquid crystal polymer, fiber, preparation method of liquid crystal polymer and fiber, and conductive fiber | 宁波聚嘉新材料科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-4204100-A1 | HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE | L'OREAL (FR) | 2023-07-05 | — | — | EP | disclosed |
| CN-116322616-A | Hair lightening compositions providing damage protection and sensory benefits and methods of use | 欧莱雅 | 2023-06-23 | — | — | CN | disclosed |
| CN-116041363-A | Benzothiophene sulfone organic crystal, preparation and application as photocatalyst | 华中科技大学 | 2023-05-02 | — | — | CN | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | disclosed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | disclosed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| WO-2001019792-A1 | COVALENTLY LINKED DIMERIC DNA BINDING MOLECULES | GENELABS TECHNOLOGIES, INC. (US) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | KDM4E 2504/4885NPC1 4765/4885RAB9A 4090/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | KDM4E 1615/4885NPC1 3829/4885RAB9A 4503/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | KDM4E 1109/4885NPC1 3993/4885RAB9A 4824/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | KDM4E 2496/4885NPC1 516/4885RAB9A 1694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.